Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $9.3500 (18.5%) ($7.8000 - $9.3800) on Tue. Mar. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.39% (three month average) | RSI | 39 | Latest Price | $9.3500(18.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 10.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -20% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(56%) ARKG(49%) IBB(47%) IWO(47%) ARKK(46%) | Factors Impacting ATRA price | ATRA will decline at least -3.695% in a week (0% probabilities). VIXM(-35%) VXX(-33%) TLT(-11%) UNG(-8%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.695% (StdDev 7.39%) | Hourly BBV | 0 () | Intraday Trend | 16.9% | | | |
|
Resistance Level | $9.82 | 5 Day Moving Average | $7.92(18.06%) | 10 Day Moving Average | $7.78(20.18%) | 20 Day Moving Average | $9.82(-4.79%) | To recent high | -47.4% | To recent low | 64.3% | Market Cap | $695m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |